Clinical Trials Browser

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Adenocarcinoma, Breast Neoplasms

Breast Neoplasms, Obesity

Breast Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

Breast Neoplasms, Folic Acid Deficiency, Ovarian Neoplasms

Breast Neoplasms

Breast Neoplasms, Sleep Initiation and Maintenance Disorders

Breast Neoplasms

Brain Neoplasms, Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

Breast Carcinoma In Situ, Breast Neoplasms

Breast Neoplasms, Carcinoma, Hepatocellular, Prostatic Neoplasms, Colorectal Neoplasms, Neuroendocrine Tumors

Breast Neoplasms, Cardiotoxicity

Breast Neoplasms

Clinical Trials

PHACS

OXYTAM

MIRHO

TDXdose

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer

REMERGE

Roll-over Study to Allow Continued Access to Ribociclib

REaCT-TEMPO

DOSABEMA

Clinical and P

CHIMTEP

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

A Study of Serum Folate Levels in Patients Treated With Olaparib

Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction

Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

SGLT2i/DPPi

An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis

REaCT-ZOL

REaCT-OGF

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

A Study of Revaree Plus in People With Breast Cancer

ODYSSEY

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

Hand and Foot Bath for Taxane-Induced Peripheral Neurotoxicity